MetaCap

Rallybio Quarterly Cash Flow Statement

NASDAQ: RLYBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

15.47-0.05 (-0.32%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Rallybio free cash flow

In the quarter ended Sep 30, 2026, Rallybio generated -$2.3 million of operating cash flow. That left free cash flow of -$2.3 million.

Summary generated from market data by MetaCap's automated system. Methodology

Rallybio cash flow statement (quarterly)

Rallybio quarterly cash flow statement
Quarter (USD)Q3 20262026-09-30Q2 20262026-06-30Q1 20262026-03-31Q4 20252025-12-31Q3 20252025-09-30Q2 20252025-06-30Q1 20252025-03-31Q4 20242024-12-31Q3 20242024-09-30Q2 20242024-06-30Q1 20242024-03-31Q4 20232023-12-31
Net Income-2.73M43.66M-8.28M-5.85M16.02M-9.70M-9.44M-11.04M-11.47M-16.24M-19.03M-20.24M
Net Income growth (YoY)-117.01%———————————
Depreciation & Amortization02.00K3.00K3.00K35.00K26.00K28.00K30.00K32.00K34.00K35.00K36.00K
Stock-Based Compensation405.00K424.00K613.00K774.00K1.05M1.61M1.88M1.96M2.03M1.92M2.09M2.55M
Change in Working Capital-498.00K1.81M-265.00K493.00K-1.19M-450.00K-3.05M-925.00K-4.43M3.80M1.30M6.06M
Operating Cash Flow-2.28M45.92M-7.98M-4.68M-6.55M-8.38M-10.21M-9.86M-13.54M-10.42M-15.46M-11.64M
Capital Expenditures———————————-12.00K
Investing Cash Flow05.50M17.90M3.92M29.23M3.04M11.08M-1.57M22.20M2.60M10.26M16.91M
Financing Cash Flow120.00K131.00K3.00K6.00K010.00K018.00K-11.00K5.19M072.00K
Net Change in Cash-2.16M51.55M9.93M-748.00K22.68M-5.33M876.00K-11.42M8.65M-2.63M-5.19M5.34M
Free Cash Flow-2.28M45.92M-7.98M-4.68M-6.55M-8.38M-10.21M-9.86M-13.54M-10.42M-15.46M-11.66M

This table shows 12 quarterly periods of Rallybio's cash flow statement, from Q3 2026 back to Q4 2023, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow RLYB's reporting calendar. What is a cash flow statement?

More financial data